tiprankstipranks
Marker Therapeutics (MRKR)
NASDAQ:MRKR
US Market
MRKR
Marker Therapeutics
RESEARCH TOOLSreports
Want to see MRKR full AI Analyst Report?

Marker Therapeutics (MRKR) Income Statement

603 Followers

Marker Therapeutics Income Statement

Last quarter (Q4 2025), Marker Therapeutics's total revenue was $1.10M, an increase of 216.08% from the same quarter last year. In Q4, Marker Therapeutics's net income was $-1.70M. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 3.55M$ 6.59M$ 3.31M$ 3.51M$ 1.24M
Gross Profit
$ 0.00$ -6.88M$ -7.11M$ -8.45M$ -1.92M
Operating Expenses
$ 15.98M$ 4.24M$ 7.48M$ 11.34M$ 37.56M
Depreciation and Amortization
$ 0.00$ 2.00$ 2.79M$ 2.79M$ 3.16M
EBITDA
$ -12.44M$ -11.12M$ -11.79M$ -17.00M$ -38.72M
Operating Income
$ -12.44M$ -11.12M$ -14.58M$ -19.79M$ -39.48M
Other Income/Expenses
$ 258.51K$ 437.01K$ 539.16K$ 15.09K$ -2.40M
Pretax Income
$ -12.18M$ -10.68M$ -14.04M$ -19.78M$ -41.88M
Net Income
$ -12.16M$ -10.73M$ -8.24M$ -29.93M$ -41.88M
Per Share Metrics
Basic EPS
$ -0.79$ -1.19$ -1.93$ -3.58$ -5.47
Diluted EPS
$ -0.79$ -1.19$ -1.93$ -3.58$ -5.47
Weighted Average Shares Outstanding
 15.31M 8.98M 8.81M 8.35M 7.65M
Weighted Average Shares Outstanding (Diluted)
 15.31M 8.98M 8.81M 8.35M 7.65M
Currency in USD

Marker Therapeutics Earnings and Revenue History